Zacks Company Profile for Utah Medical Products, Inc. (UTMD : NSDQ) |
|
|
|
Company Description |
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
Number of Employees: 167 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $57.59 |
Daily Weekly Monthly
 |
20 Day Moving Average: 21,085 shares |
Shares Outstanding: 3.25 (millions) |
Market Capitalization: $187.06 (millions) |
Beta: 0.28 |
52 Week High: $77.33 |
52 Week Low: $51.26 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
0.49% |
-2.53% |
12 Week |
8.60% |
-5.86% |
Year To Date |
-6.31% |
-11.49% |
|
|
|
|
|
Address & Contact Information |
Street Address |
Phone / Fax |
Email Address |
Web URL |
7043 South 300 West - Midvale,UT 84047 USA |
ph: 801-566-1200 fax: 801-566-7305 |
None |
http://www.utahmed.com |
|
|
|
General Corporate Information |
Officers
Kevin L. Cornwell - Chief Executive Officer
Brian L. Koopman - Principal Financial Officer
James H. Beeson - Director
Ernst G. Hoyer - Director
Barbara A. Payne - Director
|
|
Peer Information
Utah Medical Products, Inc. (BJCT)
Utah Medical Products, Inc. (CADMQ)
Utah Medical Products, Inc. (APNO)
Utah Medical Products, Inc. (UPDC)
Utah Medical Products, Inc. (IMTIQ)
Utah Medical Products, Inc. (CYGN)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 917488108
SIC: 3841
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/24/25
|
|
Share - Related Items
Shares Outstanding: 3.25
Most Recent Split Date: 3.00 (1.50:1)
Beta: 0.28
Market Capitalization: $187.06 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 2.12% |
Current Fiscal Quarter EPS Consensus Estimate: $ |
Indicated Annual Dividend: $1.22 |
Current Fiscal Year EPS Consensus Estimate: $ |
Payout Ratio: 0.32 |
Number of Estimates in the Fiscal Year Consensus: |
Change In Payout Ratio: 0.03 |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: 06/16/2025 - $0.31 |
Next EPS Report Date: 07/24/25 |
|
|
|
|